Format

Send to

Choose Destination
Yale J Biol Med. 2012 Sep;85(3):347-61. Epub 2012 Sep 25.

Integrated analysis of tumor samples sheds light on tumor heterogeneity.

Author information

1
Department of Pathology and Yale Cancer Center, Yale School of Medicine, New Haven, CT 06520, USA.

Abstract

The heterogeneity of tumor samples is a major challenge in the analysis of high-throughput profiling of tumor biopsies and cell lines. The measured aggregate signals of multigenerational progenies often represent an average of several tumor subclones with varying genomic aberrations and different gene expression levels. The goal of the present study was to integrate copy number analyses from SNP-arrays and karyotyping, gene expression profiling, and pathway analyses to detect heterogeneity, identify driver mutations, and explore possible mechanisms of tumor evolution. We showed the heterogeneity of the studied samples, characterized the global copy number alteration profiles, and identified genes whose copy number status and expression levels were aberrant. In particular, we identified a recurrent association between two BRAF(V600E) and BRAF(V600K) mutations and changes in DKK1 gene expression levels, which might indicate an association between the BRAF and WNT pathways. These findings show that the integrated approaches used in the present study can robustly address the challenging issue of tumor heterogeneity in high-throughput profiling.

KEYWORDS:

SNP arrays; copy number; melanoma; next generation sequencing

PMID:
23012583
PMCID:
PMC3447199
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center